We examined serum amyloid protein A (SAA) 
than in bacterial infections. Consequently, a more sensitive marker of inflammation is needed for viral infections. In this report, we compared the amounts of SAA and CRP in sera obtained from patients with viral infections, bacterial infections, and muco-cutaneous lymph node syndrome (MCLS; Kawasaki disease), which are representative of acute inflammatory diseases in children.
Materials and Methods

Patients
Patients were admitted to Saiseikai Central Hospital. intensity of the scattered light after the addition of latex reagent was measured. SAA-enriched high-density lipoprotein, in which SAA content was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, was used as the assay standard as previously reported (17) . Concentrations of CR1' were also assayed by LA, with use of latex particles coated with antibodies to CR1' (18). The detection limit was 1 mgfL for both proteins.
Those with lower
Results
Concentrations of SM and CAP in Viral Infections
The changes in the concentrations of SAA and CR1' during infection are shown in Figure 1 
Concentrationsof SM and CRP in Bacterial Infections
The changes in the concentrations of SAA and CR1' during infection are shown in Figure 2 . In eight MCLS cases, the mean concentration of SAA was 513 mgfL, decreasing to 29 mg/L 1 week later. The mean concentration of CR1' was 81 mg/L in the acute stage and decreased to 16mg/Li week later. The concentrations of SAA and CR1' decreased to normal range (SAA <10 mg/L, CR1' <3 mg/L) by 2 or 3 weeks later (data not shown). In bacterial enterocolitis, urinary tract infection, and infection with M. pneumoniae, the concentrations of SAA and CR1' returned to normal after 1 week.
In general, changes in the SAA concentration between the acute stage and the convalescent stage paralleled that of the CR1' concentration in both viral and bacterial infections. We compared the disappearance of SAA and CR1' in patients infected with RSV and those infected with M. pneumoniae, which involved a considerable number of patients. We defined as day 1 of illness the day when the patient had an axillary body temperature >38 #{176}C. The changes in SAA and CR1' concentrations are shown in Figure 3 . In the patients infected with M. pneumoniae, SAA decreased in parallel with CR1'. In the patients infected with RSV, however, SAA tended to disappear more quickly than CR1'.
Adeno
Influ.nza Paralnftu.nza The mean concentrations of SAA and CR1' in the acute stage were highest overall in patients with MCLS. (Table 1 ). Among patients with viral infections, the highest concentrations of SAA and CR1' were observed in patients with adenovirus infection. In patients with other viral infections, the SAA concentration ranged from 31 to 77 mg/L, whereas the CR1' concentration varied within a narrower range (5-7 mg/L). The ratio of SAA to CR1' was greatest in patients infected with measles virus and influenza virus. In the acute-stage sera overall, the concentration of SAA was 5-to 11-fold greater than that of CR1'.
RS
DiscussIon
In response to tissue injury or infection, a coordinated sequence of systemic and metabolic changes occurs, generally observed as increased serum concentrations of acute-phase proteins. McAdam et a!. (19) reported that the SAA concentration began increasing within 12 h of etiocholanolone-induced inflammation in hiiniaus, day. aft., the onset of illness day. after the onset of illness (21) reported that both rIL-1 and rJ.L-6 stimulated the liver synthesis of SAA and CR1' and that anti-rIL-6 antibodies reduced the stimulatory effect of rIL-1 on the synthesis of these proteins in vitro in human hepatocyte cultures. They suggested that IL-6 played a key role in the stimulation of synthesis of SAA and CR1' in human liver cells. SAA is thought to be the precursor of the secondary amyloid fibril protein, but the significance of the increased concentration of SAA in inflammations is still unclear (1) (2) (3) . Recently, Brinckerhoffet al. (22) reported that an SAA- (Figure 1) . In these cases, we suspect the possibility of mixed infections with bacterial agents.
It is difficult to determine whether lower respiratory infections are caused simply by viral infection or complicated with bacterial infection. When both SAA and CR1' concentrations increase, we advise initiating an appropriate antibiotic therapy on suspicion of complicated bacterial infection. SAA and CRP can be meamired by LA, a simple, sensitive, and reliable method that does not require radioieotopes and yields results in slO mm. The determination of SAA concentration by the LA method appears to be more sensitive than CR1' determinations for viral infections in clinical laboratory examination.
